Why is "Medroxyprogesterone acetate" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-05-10 15:43:12
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Medroxyprogesterone_acetate entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-05-10 and was most recently seen on 2026-05-10.
Wikipedia Overview
Medroxyprogesterone acetate (MPA), also known as depot medroxyprogesterone acetate (DMPA) in injectable form and sold under the brand name Depo-Provera among others, is a hormonal medication of the progestin type. It is used as a method of birth control and as a part of menopausal hormone therapy. It is also used to treat endometriosis, abnormal uterine bleeding, paraphilia, and certain types of cancer. The medication is available both alone and in combination with an estrogen. It is taken by mouth, used under the tongue, or by injection into a muscle or fat.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
GOT1 promotes endometrial cancer progression by regulating ferroptosis through the STAT3-GPX4 axis and attenuating medroxyprogesterone acetate sensitivity - Nature
-
Use of the injectable contraceptive medroxyprogesterone acetate - epi-phare
-
Using Provera When Trying to Conceive - Parents
-
Brain Tumor Warning Added to Birth Control Shot - MedPage Today
-
Depo Provera Lawsuit Settlement | August 2026 Litigation Update - Lawsuit Information Center
-
Contraceptive Injection Use Linked to Higher Risk of Meningioma Diagnosis, But Absolute Risk Remains Low - Neurology Today
-
Depot Medroxyprogesterone Acetate Linked to Higher Risk of Meningioma in Women - Pharmacy Times
-
Medroxyprogesterone acetate and meningioma: a global issue - Frontiers
-
FDA approves label change for Depo-Provera, adding brain tumor warning - NBC News
-
Prolonged use of injectable contraceptive tied to brain tumor diagnoses - Medical Xpress
-
FDA Advisory No.2026-0733 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product “Medroxyprogesterone Acetate Tablets USP (Provera®) 10 mg Uncoated Tablets” - Food and Drug Administration - fda.gov.ph
-
Depo-Provera & Increased Risk of Brain Tumors [2026 Update] - robertkinglawfirm.com
-
DMPA Contraceptive Injection: Use and Coverage - kff.org
-
Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling - PNAS
-
Implementation Research on DMPA-SC Self-Injection - World Health Organization (WHO)
-
Brain Tumor Risk Rises With Birth Control Shot - MedPage Today
-
Depot medroxyprogesterone acetate (DMPA) enhances susceptibility and increases the window of vulnerability to HIV-1 in humanized mice - Nature
-
Can Depo-Provera Cause Brain Tumors? [2026 Update] - robertkinglawfirm.com
-
The contraceptive medroxyprogesterone acetate, unlike norethisterone, directly increases R5 HIV-1 infection in human cervical explant tissue at physiologically relevant concentrations - Nature
-
Spatial transcriptomics unveils estrogen-modulated immune responses and structural alterations in the ectocervical mucosa of depot medroxyprogesterone acetate users - Nature
-
Long-Term Clinical Outcomes of Medroxyprogesterone Acetate as Gender-Affirming Therapy - Endocrinology Advisor
-
The Risk of Deep Venous Thrombosis Associated With Injectable Depot–Medroxyprogesterone Acetate Contraceptives or a Levonorgestrel Intrauterine Device - American Heart Association Journals
-
A Rare Case of Splenic Artery Thrombosis Provoked By Medroxyprogesterone Acetate Requiring Splenectomy - Cureus
-
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 2-5 September 2024 - European Medicines Agency (EMA)
-
Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630 - Nature
-
Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection - Nature
-
Is There a Link Between Depo-Provera and Meningiomas: Women's Health Education Program Blog - Drexel University
-
The Risk of Deep Venous Thrombosis Associated With Injectable Depot–Medroxyprogesterone Acetate Contraceptives or a Levonorgestrel Intrauterine Device | Arteriosclerosis, Thrombosis, and Vascular Biology - American Heart Association Journals
-
Medroxyprogesterone Acetate Treatment for Sexually Inappropriate Behavior in a Patient With Frontotemporal Dementia - HMP Global Learning Network
-
Medroxyprogesterone acetate linked to immune suppression - Medical Xpress
-
Medroxyprogesterone Acetate Becomes a Prohibited Substance - AQHA
-
Strides to market Incepta’ contraceptive generic in Africa - pharma.economictimes.indiatimes.com
-
USEF Bans Use of Medroxyprogesterone Acetate (MPA) in Competing Horses - Eventing Nation
-
A case report and literature review: A 19-year-old with endometrial carcinoma treated with medroxyprogesterone acetate. Importance of the medical interview and endometrial examination - Wiley Online Library
-
Postmenopausal Bleeding Case with Medroxyprogesterone Acetate Therapy - Medical Professionals Reference
-
Study links birth control, menopause treatment to higher risk for brain tumors - upi.com
-
Pfizer faces huge lawsuit over brain tumours - News.com.au
-
Elevated progesterone on the trigger day does not impair the outcome of Human Menotrophins Gonadotrophin and Medroxyprogesterone acetate treatment cycles - Nature
-
USEF Board to Further Investigate Use of Medroxyprogesterone Acetate - | Eurodressage
-
Catamenial Epilepsy Treatment Approaches: What a Gynecologist Needs You to Know - Neurology Advisor
-
The effectiveness of desogestrel for endometrial protection in women with abnormal uterine bleeding-ovulatory dysfunction: a non-inferiority randomized controlled trial - Nature
-
Elevated basal luteinizing hormone does not impair the outcome of human menopausal gonadotropin and medroxyprogesterone acetate treatment cycles - Nature
-
Injectable Contraceptive is Linked to Increased Risk of Breast Cancer - CancerNetwork
-
US Federation Bans Use of Medroxyprogesterone Acetate-Commonly Called "Depo"-in Horses - dressage-news.com
-
10 Depo-Provera Birth Control Shot Side Effects to Know About - GoodRx
-
Reactions: some progesterone analogues increase risk of developing a type of brain tumour, study finds - Science Media Centre España
-
A Guide to the History of Depo-Provera - Anapol Weiss
-
Self-injected contraceptives: does the investment reflect women’s preferences? - BMJ Global Health
-
Use of injectable contraceptive, Depo-Provera, linked to increased risk of HIV - 2 Minute Medicine
-
Exploring FDA-approved birth control injections - TechTarget
-
Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15dΔ12,14,PGJ2 | Leukemia - Nature
-
Menopausal hormone therapy and dementia - BMJ Blogs
-
Hormone medication could increase risk of brain tumours, French study finds - The Guardian
-
Use of progestogens and the risk of intracranial meningioma - epi-phare
-
The power to prevent pregnancy in women’s hands: DMPA-SC injectable contraception - PATH
-
Contraception hormones medroxyprogesterone acetate, promegestone, medrogestone linked to brain tumours - AFR
-
Injectable contraception in shock link to increased risk of brain tumour - The Independent
-
Almost 20,000 Women’s Hormone Medications Recalled Nationwide - The Healthy @Reader's Digest
-
Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate - Wiley & Sons
-
Certain progestogens linked to higher brain tumor risk in women, study suggests - News-Medical
-
Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis - The New England Journal of Medicine
-
See the women's contraception used in UK linked to increased risk of brain tumour - Barrhead News
-
Injectable birth control may raise HIV infection risk by 40% - news.uct.ac.za
-
Contraceptive injection risks: Women share their harrowing experiences with Medroxyprogesterone Acetate - IOL
-
SAHPRA warns of increased brain tumour risk with specific contraceptive use - South African Government News Agency
-
‘Increased risk of brain tumours’ from birth control jab, study suggests - Irish Independent
-
NMRA warns public against use of ‘Depo’ on pets - Island.lk
-
Alert for millions of women taking contraceptive injection as study finds drug may raise risk of brain tumours by five-fold - Daily Mail
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.